Events7th International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session S6. Round table on predictive tools of the event 7th International Electronic Conference on Medicinal Chemistry
Published date
03 Nov, 2021
Academic Editor
author-avatarJean Jacques Vanden Eynde
Citation
Michal Hricovíni, Molecular structure of dermatan sulphate tetrasaccharide, in Proceedings of 7th International Electronic Conference on Medicinal Chemistry, 1 November–30 November 2021, MDPI: Basel, Switzerland, doi: 10.3390/ECMC2021-11456
Share
Email
Facebook
Twitter
LinkedIn

Molecular structure of dermatan sulphate tetrasaccharide

1. Institute of Chemistry, Slovak Academy of Sciences, Dúbravská cesta 9, 845 38 Bratislava, Slovak Republic
Abstract

Dermatan sulphate (DS) belongs to the group of glycosaminoglycan (GAG) polysaccharides. DS is present in various tissues in higher organisms, e.g. in skin, blood vessels or lungs and plays important roles in various processes. The proper knowledge of the DS chemical structure is therefore essential for understanding biological role of this GAG. The main contribution to the investigation of DS solution properties and formation of their intermolecular complexes with proteins are methods of theoretical chemistry, together with high-resolution NMR spectroscopy. In the present contribution, the results of calculations of molecular geometry of dermatan sulphate by density functional theory (DFT) are discussed and compared with experimental spectroscopic data. The data showed that the positions of sulphate groups at the pyranose rings significantly influenced the molecular structure of the investigated DS tetrasaccharide. The computed data also revealed that formation of a complex hydrogen bond network and strong ionic interactions influence the first hydration shell and plays important role in shaping the three-dimensional structure of DS tetrasaccharide.

Keywords
Dermatan sulphate
DFT
NMR
structure
Poster
Hricovini_ECMC2021.pdf
Heterologous expression, purification and enzymatic activity of aldo-keto reductase 1C4
New ruthenium-cyclopentadienyl agents as a new strategy to fight colorectal cancer